FINWIRES · TerminalLIVE
FINWIRES

$CADL

1 story mentioning CADLUpdated just now

Every FINWIRES story that references CADL, newest first.

Research

Stifel Nicolaus Initiates Coverage on Candel Therapeutics With Buy Rating, $22 Price Target

$CADL

Track with the FINWIRES app suite

FolioX
FolioX
Track CADL in your portfolio
WheelAI
WheelAI
Analyze CADL options with the wheel strategy
StockInsider
StockInsider
See market sentiment on CADL